syahrir maulana
The January market rally saw small caps leading the way, followed by mid-caps. Among small- and mid-cap moat stocks, car businesses lead.
The Morningstar US Small-Mid Cap Moat Focus Index (the “SMID Moat Index”) managed to outpace all three market cap segments of the U.S. stock market in January. The SMID Moat Index tends to provide mostly mid-cap exposure along with some small-cap exposure among those U.S. companies that benefit from sustainable competitive advantages.
Small caps led the way for the month followed by mid-caps. Large caps generally participated least in the January market rally. Despite the SMID Moat Index’s relatively lower exposure to small caps, it outperformed them by 2.25% in January. In fact, for those “moat heads” out there, the SMID Moat Index even outmatched its big sister, the Morningstar Wide Moat Focus Index, which had an equally impressive month.
Banner January for SMID Moat Investing
1 Month Total Return as of 1/31/2023
Morningstar
As of 1/31/2023. Past performance is no guarantee of future results. Index performance is not illustrative of Fund performance. Fund performance current to the most recent month end is available by visiting vaneck.com or by calling 800.826.2333. Indexes are unmanaged and are not securities in which an investment can be made.
Stock Selection a Key Contributor to January Performance
The SMID Moat Index benefited most from its exposure to consumer discretionary, industrials, and information technology companies, while no single sector, as a whole, posted negative returns within the index. With roughly 75% of its exposure in mid-cap stocks, the SMID Moat Index was highly influenced by stock selection within that market cap segment. Stock selection within smaller cap stocks, though less exposure, contributed nearly as prominently to January’s strong performance.
Notably, only five SMID Moat Index companies posted negative returns for the month: Baxter International (BAX), Kellogg Co. (K), Hasbro Inc. (HAS), Sirius XM Holdings (SIRI), and Zimmer Biomet Holdings (ZBH).
Some of the leaders are lesser known, and most are in the car business, so let’s learn a little about their economic moat and valuations.
Top SMID Moat Companies in January
Adient (ADNT)
Adient PLC is an automotive seating business that was spun off from Johnson Controls in 2016 and has about 33% share of the global seating market, according to Morningstar. While auto parts may not be the most riveting area of the market, competitive advantages make sense here. Morningstar views seating as one of the stickiest areas of the supply chain because automakers need consistent quality that can be delivered with precision all around the world. Stated differently, automakers will generally pay for the right supplier rather than seek out a low-cost provider. In fact, Morningstar notes that it is common for incumbent seating suppliers to get the next generation of a vehicle program nearly 100% of the time.
Adient is assigned a narrow moat rating by Morningstar driven by intangible assets, cost advantage, and switching costs. While its advantages are strong, it is assigned a narrow moat rather than a wide moat because of automaker customers’ growing global overcapacity and Adient’s lack of immunity to the cyclical nature of the auto industry. Morningstar believes it’s more likely than not that Adient can generate economic profit for 10 years, but for the reasons mentioned, they cannot say that it is more likely than not that Adient can generate economic profit for 20 years.
Adient’s fair value estimate was increased from $64 per share to $68 in November 2022 to reflect continued operation improvement over time. Adient was a victim of the global chip shortages and high steel and chemical input costs which drove negative sentiment in recent periods, according to Morningstar. The company finished the month at a 30% discount to Morningstar’s fair value estimate.
Lithia Motors (LAD)
Lithia Motors is a publicly traded auto dealer that has created a differentiated business as the only public dealer to operate in rural markets. In fact, many Lithia brand stores have no competitors within 100 miles, according to Morningstar. The dealer, like some other publicly traded dealers, benefits from cost advantages and intangible assets. It also enjoys a lack of competition for many vehicle brands given its focus on rural areas. Morningstar believes public dealers enjoy several benefits over private dealers, such as centralized back-office operations and much higher volumes, which brings scale. They are also not dependent on any one vehicle brand as many have a diversified portfolio of dealerships.
Morningstar sees parts and service operations at Lithia as a strong advantage as well. Customers are prone to return to a dealer for service because of warranties or proximity to home and expertise to service a particular vehicle. Obtaining multiple quotes on a vehicle repair can be very time-consuming. All of this leads to inelasticity of demand and stronger pricing power for dealers, according to Morningstar.
For the better part of the decade, Lithia has traded close to Morningstar’s fair value. Outside of the market selloff in March 2022, Lithia shares have not traded at such a steep discount to fair value in the last 10 years. Shares ended January at approximately a 40% discount.
Sensata Technologies (ST)
Staying on the automobile theme, Sensata Technologies is a supplier of sensors and electrical protection, predominantly for the automotive market. It has positioned itself well to participate in secular trends toward electrification, efficiency, and connectivity, according to Morningstar.
Sensata’s narrow moat rating is attributable primarily to switching costs. Its sensors and controls are often part of mission-critical processes related to electric vehicle battery management systems, avionics systems, and power grids. As Morningstar explains it, once a supplier’s component is designed into an end application, it is likely to remain in the product’s entire lifecycle-ranging from five to seven years in cars and more than 10 years in aerospace applications. Morningstar believes Sensata also boasts robust design and engineering abilities, exhibiting intangible assets that supplement its moat.
After closing January at under $53 per share, Sensata was over 25% discounted relative to its Morningstar fair value estimate.
Asbury Automotive Group (ABG)
ABG, like Lithia Motors, is a publicly traded auto dealer and benefits from similar cost advantages and intangible assets. ABG operates nearly 150 dealerships and generates the overwhelming majority of its revenue from the luxury automobile segment. This makes it slightly more recession-proof, as customers of luxury brands tend to have higher-than-average incomes and can often afford new cars and maintenance through economic cycles.
Morningstar raised its fair value estimate substantially in April 2022 from $233 per share to $377 based on the company’s growth trajectory. Following a strong fourth quarter 2022, Morningstar has maintained its fair value estimate.
ICU Medical (ICUI)
ICU Medical is a comprehensive infusion and IV provider offering infusion consumables, infusion pumps, and IV solution manufacturing. Morningstar believes its unrivaled scale in consumables allows ICU to offer rock-bottom prices that competitors would be hard-pressed to beat and gives them confidence in the firm’s ability to generate excess returns over the coming decade. ICU Medical also benefits, to a lesser degree, from switching costs in its infusion systems segment.
Like medical technology firms that benefit from intellectual property and regulatory factors that limit competition, only a handful of competitors in ICU’s markets possess meaningful scale. As Morningstar explains, infusion consumables are the relatively commodity-like parts that are used in IV administration. They include a wide array of mostly plastic parts such as IV sets, IV connectors, closed system transfer devices, disinfecting caps, and more. ICU Medical has the leading U.S. market share in this segment. Morningstar does not see this changing anytime soon, because ICU Medical is able to price its consumables at a significant discount to market, attracting hospitals and other health providers.
After trading at a steep discount to fair value throughout much of 2022, ICU Medical is now trading near fair value.
Top Contributors and Detractors from SMID Moat Index
January 2023
| Leading Contributors | ||||
| Name | Ticker | Sector | Avg. Weight | Contribution (%) |
| Adient PLC | ADNT | Consumer Discretionary | 1.42 | 0.42 |
| Lithia Motors Inc | LAD | Consumer Discretionary | 1.19 | 0.34 |
| Sensata Technologies Holdings | ST | Industrials | 1.28 | 0.33 |
| Asbury Automotive Group Inc | ABG | Consumer Discretionary | 1.43 | 0.32 |
| ICU Medical Inc | ICUI | Health Care | 1.33 | 0.30 |
| Leading Detractors | ||||
| Name | Ticker | Sector | Avg. Weight | Contribution (%) |
| Baxter International Inc | BAX | Health Care | 1.22 | -0.13 |
| Kellogg Co | K | Consumer Staples | 1.30 | -0.05 |
| Sirius XM Holdings Inc | SIRI | Communication Services | 1.27 | -0.01 |
| Zimmer Biomet Holdings Inc | ZBH | Health Care | 1.41 | -0.00 |
| Tyler Technologies | TYL | Information Technology | 0.59 | 0.00 |
Source: Morningstar. As of 1/31/2023. Past performance is no guarantee of future results. Not intended as a recommendation to buy or sell any of the securities mentioned herein.
VanEck Morningstar SMID Moat ETF (SMOT) seeks to track as closely as possible, before fees and expenses, the price and yield performance of the Morningstar US Small-Mid Cap Moat Focus Index.
Important Disclosures
Source for all data unless otherwise noted: Morningstar.
Fair value estimate: the Morningstar analyst’s estimate of what a stock is worth. Price/Fair Value: ratio of a stock’s trading price to its fair value estimate.
This is not an offer to buy or sell, or a recommendation to buy or sell any of the securities/financial instruments mentioned herein. The information presented does not involve the rendering of personalized investment, financial, legal, or tax advice. Certain statements contained herein may constitute projections, forecasts and other forward looking statements, which do not reflect actual results, are valid as of the date of this communication and subject to change without notice. Information provided by third party sources are believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. VanEck does not guarantee the accuracy of third party data. The information herein represents the opinion of the author(s), but not necessarily those of VanEck or its employees.
Holdings will vary for the SMOT ETF and its corresponding Index. For a complete list of holdings in the ETF, please click here: https://www.vaneck.com/etf/equity/smot/holdings/
Holdings will vary for the MOAT ETF and its corresponding Index. For a complete list of holdings in the ETF, please click here: https://www.vaneck.com/etf/equity/moat/holdings/
An investor cannot invest directly in an index. Returns reflect past performance and do not guarantee future results. Results reflect the reinvestment of dividends and capital gains, if any. Certain indices may take into account withholding taxes. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
The Morningstar® Wide Moat Focus IndexSM and Morningstar® US Small-Mid Cap Moat Focus IndexSM were created and are maintained by Morningstar, Inc. Morningstar, Inc. does not sponsor, endorse, issue, sell, or promote the VanEck Morningstar Wide Moat ETF or the VanEck Morningstar SMID Moat ETF and bears no liability with respect to the ETFs or any security. Morningstar® is a registered trademark of Morningstar, Inc. Morningstar® Wide Moat Focus IndexSM and Morningstar® US Small-Mid Cap Moat Focus IndexSM are service marks of Morningstar, Inc.
The Morningstar moat-driven indexes represent various regional exposures and consist of companies identified as having sustainable, competitive advantages and whose stocks are attractively priced, according to Morningstar.
The Morningstar® US Small-Mid Cap Moat Focus IndexSM is intended to track the overall performance of small- and mid-cap companies with sustainable competitive advantages and attractive valuations according to Morningstar’s equity research team.
Russell 2500 Index represents small- and mid-cap US companies. Russell 2000 Index represents small-cap US companies. Russell Midcap Index provides investors with a benchmark for mid-sized US companies. Russell 1000 Index represents larger cap US companies. Morningstar Wide Moat Focus Index represents attractively priced wide moat US companies.
An investment in the VanEck Morningstar SMID Moat ETF (SMOT) may be subject to risks which include, among others, risks related to investing in equity securities, small- and medium-capitalization companies, consumer discretionary sector, financials sector, health care sector, industrials sector, information technology sector, market, operational, high portfolio turnover, index tracking, authorized participant concentration, new fund, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium/discount and liquidity of fund shares, non-diversified, and index-related concentration risks, all of which may adversely affect the Fund. Small- and medium-capitalization companies may be subject to elevated risks.
An investment in the VanEck Morningstar Wide Moat ETF (MOAT) may be subject to risks which include, among others, risks related to investing in equity securities, consumer discretionary sector, health care sector, industrials sector, information technology sector, financials sector, medium-capitalization companies, market, operational, high portfolio turnover, index tracking, authorized participant concentration, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium/discount risk and liquidity of fund shares, non-diversification and index-related concentration risks, all of which may adversely affect the Fund. Medium-capitalization companies may be subject to elevated risks.
Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of a Fund carefully before investing. To obtain a prospectus and summary prospectus, which contain this and other information, call 800.826.2333 or visit vaneck.com. Please read the prospectus and summary prospectus carefully before investing.
©️ Van Eck Securities Corporation, Distributor, a wholly owned subsidiary of Van Eck Associates Corporation.
Editor’s Note: The summary bullets for this article were chosen by Seeking Alpha editors.
Be the first to comment